InvestorsHub Logo
Followers 7
Posts 444
Boards Moderated 0
Alias Born 01/22/2006

Re: biopharm post# 246760

Saturday, 12/26/2015 8:21:13 AM

Saturday, December 26, 2015 8:21:13 AM

Post# of 345979
Biopharm, shouldn't that NASD Rule 2711 that you highlighted in red make us a tad nervous? As it read it, Piper Jaffrey must have materially substantive reasons for terminating coverage of a company they know so much about, and that they would be in trouble if it were for a reason such as "pique" with PPHM as has been suggested. Am I missing something? TIA.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CDMO News